Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A single "supraphysiological" course of exogenous corticosteroids is recommended between 24-34 weeks' gestation to minimize the adverse sequelae associated with prematurity. The 24-hour profile of endogenous corticosteroids normally follows a diurnal rhythm with the highest serum level occurs between 5am-11am and nadir over 12 hours.
A retrospective study from January 2010 to December 2017. Eligible for analysis are: singleton pregnancies between 24 - 34 weeks' gestation who were given a single course of intramuscular betamethasone. Single course comprised of two separate doses of 12 mg given 24 hours apart. Each woman was allocated into one of the four pre-defined groups based on the time the intramuscular betamethasone was administered; Group 1 (5am-11am), group 2 (11am-5pm), group 3 (5pm-11pm) and group 4 (11pm-5am). The investigators hypothesized that exogenous corticosteroids given during the nadir state of endogenous corticosteroids activity could alter maternal and fetal glucose homeostasis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Betamethasone group 1 | Betamethasone Group 1 (5am-11am) |
| |
| Betamethasone Group 2 | Betamethasone Group 2 (11am-5pm) |
| |
| Betamethasone Group 3 | Betamethasone Group 3 (5pm-11pm) |
| |
| Betamethasone Group 4 | Betamethasone Group 4 (11pm-5am). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Betamethasone | Drug | Corticosteroids |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of neonatal hypoglycemia | Incidence of neonatal hypoglycemia, glucose Ë‚ 40 mg/dL at any time | 7 years |
Not provided
Not provided
Inclusion Criteria:
• women between 24 - 34 weeks' gestation who were admitted and given a single course of intramuscular betamethasone for threatened preterm labor in our institution
Exclusion Criteria:
Pregnant women and their newborns
Not provided
Not provided
This is a retrospective study at Rambam Health Care Campus.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yaniv Zipori, M.D | Contact | +972 58 7966963 | y_zipori@rambam.health.gov.il |
| Name | Affiliation | Role |
|---|---|---|
| Yaniv Zipori, M.D | Rambam Health Care Campus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rambam health care campus | Haifa | Israel |
The study is expected to be published after completion
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007003 | Hypoglycemia |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001623 | Betamethasone |
| ID | Term |
|---|---|
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
Not provided
Not provided
Not provided
Not provided
Not provided
| D000072473 |
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |